Nalaganje...
miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling
Recombinant tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), as a novel cancer therapeutic, is being tested in phase II and III clinical trials; however, TRAIL resistance remains a big obstacle preventing its clinical application. Considering that TRAIL-induced apoptosis throug...
Shranjeno v:
| izdano v: | Mol Ther Nucleic Acids |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Gene & Cell Therapy
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5560119/ https://ncbi.nlm.nih.gov/pubmed/28918048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2017.07.015 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|